Rare disease focus Mendelian specializes in software to help doctors diagnose rare diseases earlier, presenting a sales opportunity to expand into healthcare providers, hospitals, and clinics that manage undiagnosed patient cohorts and require tools to streamline diagnosis workflows.

Public funding traction Past government grants and Innovate UK funding indicate a proven track record with public funding bodies and potential for continued grant-backed partnerships or pilot programs to extend their platform within NHS-linked networks.

Collaborative pilots Existing partnerships with academic health networks and regional NHS entities suggest a pathway to scale via co-funded pilots, offering a route to demonstrate value at scale with real patient data and compliance.

Tech stack fit Stack includes Kubernetes, EKS, Terraform and Elasticsearch, signaling a modern cloud-native architecture that aligns with enterprise clients seeking scalable, secure, and compliant health tech solutions.

Early-stage funding needs Revenue is modest and total funding is $1.7M, indicating a potential need for additional capital to accelerate go-to-market efforts, expand sales, and broaden product features for larger healthcare buyers.